Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C121 - Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication

Tuesday 04/25/23
07:00 AM - 09:00 AM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Matthew Kirschen, MD, PhD, FAAN
Neuro Trauma and Critical Care
Participants will understand the use of integrated multimodal neurophysiologic modalities to optimize neuroprotective strategies in children with acute brain injury; understand how to use quantitative electroencephalographic features toward seizure detection, encephalopathy grading, and managing ictal-interictal continuum in critically ill children; and understand the strategic use of neuromodulatory therapy in critically ill children with a suspected neuroinflammatory disorder.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based

Program Materials Program Evaluations

Event Timeline
07:00 AM - 08:00 AM EST Speaker Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury
Brian L. Appavu, MD
07:00 AM - 08:00 AM EST Speaker Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury
Matthew Kirschen, MD, PhD, FAAN
07:00 AM - 08:00 AM EST Speaker Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury
Giulia Benedetti, MD
07:00 AM - 08:00 AM EST Speaker Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury
France W. Fung, MD
08:00 AM - 09:00 AM EST Speaker Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema
Matthew Kirschen, MD, PhD, FAAN
08:00 AM - 09:00 AM EST Speaker Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema
Craig A. Press, MD, PhD
08:00 AM - 09:00 AM EST Speaker Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema
Sona Narula, MD
08:00 AM - 09:00 AM EST Speaker Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema
Kristin Guilliams, MD
Faculty Disclosures
Matthew Kirschen, MD, PhD, FAAN The institution of Dr. Kirschen has received research support from NIH.
Craig A. Press, MD, PhD Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
Brian L. Appavu, MD Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
Sona Narula, MD Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Giulia Benedetti, MD Dr. Benedetti has nothing to disclose.
France W. Fung, MD Dr. Fung has nothing to disclose.
Kristin Guilliams, MD Dr. Guilliams has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wiseman Ashworth Law Group. The institution of Dr. Guilliams has received research support from NIH.